Jenburkt Pharmaceuticals Ltd Share Price
(524731)
₹1022▲1.02%
as on 04:01PM, 01 Apr 2025
Jenburkt Pharmaceuticals Ltd Performance
Day's Low
Day's High
₹990Day's Price Range₹1,03252 Week's Low
52 Week's High
₹701.252-Week Price Range₹1,375
| Returns % | |
| 1 Month Return | + 2.31 % |
| 3 Month Return | -17.05 % |
| 1 Year Return | + 42.38 % |
| Market Stats | |
| Previous Close | ₹1,011.70 |
| Open | ₹1,000.05 |
| Volume | 422.00 |
| Upper Circuit | ₹1,214.00 |
| Lower Circuit | ₹809.40 |
| Market Cap | ₹446.49Cr |
Jenburkt Pharmaceuticals Ltd Fundamentals
P/E Ratio
0PEG Ratio
0Market Cap
₹446.49 Cr
P/B Ratio
2.1
EPS
0Dividend Yield
0Sector
Pharmaceuticals
ROE
19.44
Key events for Jenburkt Pharmaceuticals Ltd
Jenburkt Pharma Reports Strong Q4 Results - 29 Jan, 2025
Jenburkt Pharma's standalone net sales for December 2024 reached Rs 36.89 crore, up 3.46% YoY. Net profit increased by 20.41% to Rs 6.51 crore, while EBITDA rose 21.78% to Rs 10.40 crore. EPS improved to Rs 14.75. The stock closed at Rs 1,198.20, reflecting 28.20% returns over the last 6 months and 38.97% over the last year.
Insights on Jenburkt Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 1 year, Jenburkt Pharma stock has moved up by 42.4%
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 131.7% return, outperforming this stock by 55.9%
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 61.9% return, outperforming this stock by 19.5%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 53.29% to 53.20% in Dec 2024 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 46.71% to 46.69% in Dec 2024 quarter
Jenburkt Pharmaceuticals Ltd Financials
Jenburkt Pharmaceuticals Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 46.69% | ||
| Foreign Institutions | 0% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 53.2% | ||
| Others | 0.12% | 0.00 |
Jenburkt Pharmaceuticals Ltd Key Indicators
Jenburkt Pharmaceuticals Ltd Earnings and Dividends
Jenburkt Pharmaceuticals Ltd Earnings Results
Jenburkt Pharmaceuticals Ltd’s net profit jumped 20.56% since last year same period to ₹6.51Cr in the Q3 2024-2025. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated -32.19% fall in its net profits since last 3-months.
Read More about Earnings ResultsJenburkt Pharmaceuticals Ltd Dividends May,2024
In the quarter ending March 2024, Jenburkt Pharmaceuticals Ltd has declared dividend of ₹15.30 - translating a dividend yield of 1.50%.
Read More about Dividends
Jenburkt Pharmaceuticals Ltd Technicals Summary
Bearish
Neutral
Bullish
Jenburkt Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
Jenburkt Pharmaceuticals Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹446.49 Cr | 47.06% | 0.51 | NA | NA | |
| NA | ₹747.62 Cr | 34.1% | 0.51 | NA | NA | |
| NA | ₹2,116.87 Cr | 16.93% | 0.79 | NA | NA | |
| NA | ₹190.52 Cr | 110.43% | 0.66 | ₹5 Cr | ₹155 Cr | |
| NA | ₹65.86 Cr | 136.6% | 0.80 | NA | NA |
About Jenburkt Pharmaceuticals Ltd
Founders of the company, the Bhuta family, help maintain the core values of Jenburkt, as over 35 years of experience in the pharmaceutical industry ensures that its products meet the highest standards of quality and efficiency. With a stellar history and experience in the field, Jenburkt continues to serve the healthcare industry with its unique solutions and services.
Chairperson Name: Ashish U Bhuta
| Organisation | Jenburkt Pharmaceuticals Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Jenburkt Pharmaceuticals Ltd
What is Jenburkt Pharmaceuticals Ltd price today?
Jenburkt Pharmaceuticals Ltd share price today stands at ₹1022, Open: ₹1000.05, Previous Close: ₹1011.7, High: ₹1032, Low: ₹990, 52 Week High: ₹1375, 52 Week Low: ₹701.2.
How to Buy Jenburkt Pharmaceuticals Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Jenburkt Pharmaceuticals Ltd shares
What are today's traded volumes of Jenburkt Pharmaceuticals Ltd?
Today's traded volume of Jenburkt Pharmaceuticals Ltd(524731) is 422.00.
What is today's market capitalisation of Jenburkt Pharmaceuticals Ltd?
Today's market capitalisation of Jenburkt Pharmaceuticals Ltd(524731) is ₹446.49Cr.
What is the 52 Week High and Low Range of Jenburkt Pharmaceuticals Ltd?
How much percentage Jenburkt Pharmaceuticals Ltd is down from its 52 Week High?
Jenburkt Pharmaceuticals Ltd (524731) share price is ₹1022. It is down -25.67% from its 52 Week High price of ₹1375
How much percentage Jenburkt Pharmaceuticals Ltd is up from its 52 Week low?
Jenburkt Pharmaceuticals Ltd (524731) share price is ₹1022. It is up 45.75% from its 52 Week Low price of ₹701.2